Optical genome mapping identified a previously uncharacterized ENOX2::RUNX1 rearrangement in a patient with acute myeloid leukemia–myelodysplasia related, after routine genetic testing reportedly failed to yield a molecular diagnosis. The case underscores how structural-variant–focused technologies can resolve breakpoint architecture that standard workflows may miss. Clinicians reported a 59-year-old woman with neurologic symptoms and anemia, with subsequent bone marrow findings consistent with AML-MDS related. The discovery was framed as the first described instance of the specific fusion pairing, resolved using optical genome mapping’s capacity to map large structural changes across intact DNA molecules.
Get the Daily Brief